IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 16 July 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.00465-07v1
75/9/4638    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marks, E.
Right arrow Articles by Lycke, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marks, E.
Right arrow Articles by Lycke, N.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.00465-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Differential CD28 and ICOS signaling requirements for protective CD4+ T cell mediated immunity against genital tract Chlamydia trachomatis infection

Ellen Marks, Martina Verolin, Anneli Stensson, and Nils Lycke*

Department of Microbiology and Immunology, Mucosal Immunobiology and Vaccine Research Center, Institute of Biomedicine, Gothenburg University, Box 435, 40530 Gothenburg, Sweden; Department of Clinical Immunology, Gothenburg University, Box 435, 40530 Gothenburg, Sweden

* To whom correspondence should be addressed. Email: nils.lycke{at}microbio.gu.se.


   Abstract

Th1 cells and IFN-{gamma} production play critical roles in protective immunity against genital tract infections with C. trachomatis. Here we show that ICOS-/- mice develop greatly augmented host resistance against chlamydial infection. Protection following a primary infection was characterized by strong Th1 immunity with enhanced CD4+ T cell mediated IFN-{gamma} production in the genital tract and high expression of T-bet in the draining paraaortic lymph node (PALN). This Th1 dominance was associated with low expression of IL-10 mRNA in the uterus of protected ICOS-/- mice. By contrast, CD28-/- mice were severely impaired in their adaptive immune response, demonstrating lack of CD4+ T cells and IFN-{gamma} in the genital tract with a substantial delay in bacterial elimination compared to that seen in WT mice. Upon reinfection WT mice exhibited a transient local infection with evidence of Treg/Foxp3 mRNA and a more balanced Th1 and Th2 response in the genital tract than ICOS-/- mice, whereas 90% of the latter mice developed sterile immunity, poor local Treg/Foxp3 mRNA and macroscopic signs of enhanced local immunopathology. Therefore, differential requirements for CD28- and ICOS-signaling clearly apply to host protection against a genital tract infection with C. trachomatis. Whereas, CD28-signaling is critical, ICOS appears to be dispensable and can have a dampening effect on Th1-development by driving Th2-immunity and anti-inflammation through IL-10 production and promoting Foxp3+ Treg populations in the genital tract. Both CD28- and ICOS-deficient mice demonstrated poor specific antibody production, supporting that antibodies are not needed for protection against genital tract chlamydial infections.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.